Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, January 1999, p. 178-180, Vol. 43, No. 1
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Antimicrobial Resistance of 914 Beta-Hemolytic
Streptococci Isolated from Pharyngeal Swabs in Spain: Results of a
1-Year (1996-1997) Multicenter Surveillance Study
Fernando
Baquero,1
José Angel
García-Rodríguez,2
Juan García
de
Lomas,3
Lorenzo
Aguilar,4,* and
the
Spanish Surveillance Group for Respiratory
Pathogens
Microbiology Department, Ramón y Cajal
Hospital,1 and
Medical Department,
SmithKline Beecham Pharmaceuticals,4 Madrid,
Microbiology Department, University Hospital,
Salamanca,2 and
Instituto Valenciano de
Microbiología, Valencia,3 Spain
Received 26 May 1998/Returned for modification 22 July
1998/Accepted 5 October 1998
A nationwide susceptibility surveillance study of beta-hemolytic
streptococcal isolates from pharyngeal swabs obtained in 11 Spanish
hospitals between May 1996 and April 1997 against 12 antibiotics was
carried out. Of the isolates 86% (786 of 914 isolates) were group A
and 8.4% (77 of 914 isolates) were group C. No resistance was found to
-lactam antibiotics, but significant differences (P < 0.001) with respect to lack of susceptibility to macrolides were found between groups (27% for group A and 12% for group C) and
between seasons (13.2% in summer and 31.7% in winter). Most of these
isolates displayed the M phenotype (low-level resistance to
erythromycin and susceptibility to clindamycin).
*
Corresponding author. Mailing address: Departamento
Médico, SmithKline Beecham Pharmaceuticals, Valle de la
Fuenfría, 3, 28034 Madrid, Spain. Phone: 34-91-3345275. Fax:
34-91-3345141. E-mail: lorenzo.aguilar-alfaro{at}sb.com.
Composed of M. Gobernado and N. Diosdado, La Fe Hospital, Valencia;
E. Bouza and E. Cercenado, Gregorio Marañón Hospital, Madrid; A. Gutierrez and A. García, La Paz Hospital,
Madrid; R. Cisterna and A. Morla, Basurto Hospital, Bilbao; E. Perea and L. Martínez, Virgen Macarena Hospital, Seville;
M. de la Rosa and A. Martínez-Brocal, Virgen de las Nieves
Hospital, Granada; M. Casal and A. Ibarra, Reina Sofía
Hospital, Córdoba; I. Trujillano, Clinico Universitario Hospital,
Salamanca; R. Gómez-Lus and M. C. Rubio, Clinico
Universitario Hospital, Zaragoza; A. C. Gómez-García and F. J. Blanco-Palenciano, Infanta
Cristina Hospital, Badajoz; C. García-Riestra and I. Rodríguez, Xeral de Galicia Hospital, Santiago de Compostela;
C. Gimeno and D. Navarro, Instituto Valenciano de
Microbiología, Valencia; and A. Torrellas, J. J. Granizo, R. Moreno, and R. Dal-Ré, SmithKline Beecham
Pharmaceuticals, Madrid, Spain.
Antimicrobial Agents and Chemotherapy, January 1999, p. 178-180, Vol. 43, No. 1
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Richter, S. S., Heilmann, K. P., Dohrn, C. L., Beekmann, S. E., Riahi, F., Garcia-de-Lomas, J., Ferech, M., Goossens, H., Doern, G. V.
(2008). Increasing telithromycin resistance among Streptococcus pyogenes in Europe. J Antimicrob Chemother
61: 603-611
[Abstract]
[Full Text]
-
Alberti, S., Garcia-Rey, C., Dominguez, M. A., Aguilar, L., Cercenado, E., Gobernado, M., Garcia-Perea,, A.
(2003). Survey of emm Gene Sequences from Pharyngeal Streptococcus pyogenes Isolates Collected in Spain and Their Relationship with Erythromycin Susceptibility. J. Clin. Microbiol.
41: 2385-2390
[Abstract]
[Full Text]
-
Alos, J. I., Aracil, B., Oteo, J., Gomez-Garces, J. L., the Spanish Group for the Study of Infection in th,
(2003). Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain. J Antimicrob Chemother
51: 333-337
[Abstract]
[Full Text]
-
Sauermann, R., Gattringer, R., Graninger, W., Buxbaum, A., Georgopoulos, A.
(2003). Phenotypes of macrolide resistance of group A streptococci isolated from outpatients in Bavaria and susceptibility to 16 antibiotics. J Antimicrob Chemother
51: 53-57
[Abstract]
[Full Text]
-
Latorre, C., Garcia-Rey, C., Garcia-Perea, A., Perea, E., Aguilar, L., Cercenado, E., Garcia-de-Lomas, J., the Spanish Surveillance Group for Respiratory Pat,
(2002). Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin. J Antimicrob Chemother
50: 301-303
[Full Text]
-
Cresti, S., Lattanzi, M., Zanchi, A., Montagnani, F., Pollini, S., Cellesi, C., Rossolini, G. M.
(2002). Resistance Determinants and Clonal Diversity in Group A Streptococci Collected during a Period of Increasing Macrolide Resistance. Antimicrob. Agents Chemother.
46: 1816-1822
[Abstract]
[Full Text]
-
Perez-Trallero, E., Fernandez-Mazarrasa, C., Garcia-Rey, C., Bouza, E., Aguilar, L., Garcia-de-Lomas, J., Baquero, F., The Spanish Surveillance Group for Respiratory Pat,
(2001). Antimicrobial Susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes Isolates and Their Ecological Relationships: Results of a 1-Year (1998-1999) Multicenter Surveillance Study in Spain. Antimicrob. Agents Chemother.
45: 3334-3340
[Abstract]
[Full Text]
-
Weber, P., Filipecki, J., Bingen, E., Fitoussi, F., Goldfarb, G., Chauvin, J. P., Reitz, C., Portier, H.
(2001). Genetic and phenotypic characterization of macrolide resistance in group A streptococci isolated from adults with pharyngo-tonsillitis in France. J Antimicrob Chemother
48: 291-294
[Abstract]
[Full Text]
-
Cercenado, E., Garcia-Garrote, F., Bouza, E.
(2001). In vitro activity of linezolid against multiply resistant Gram-positive clinical isolates. J Antimicrob Chemother
47: 77-81
[Abstract]
[Full Text]
-
Palavecino, E. L., Riedel, I., Berrios, X., Bajaksouzian, S., Johnson, D., Kaplan, E., Jacobs, M. R.
(2001). Prevalence and Mechanisms of Macrolide Resistance in Streptococcus pyogenes in Santiago, Chile. Antimicrob. Agents Chemother.
45: 339-341
[Abstract]
[Full Text]
-
Granizo, J. J., Aguilar, L., Casal, J., Dal-Re, R., Baquero, F.
(2000). Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997). J Antimicrob Chemother
46: 959-964
[Abstract]
[Full Text]
-
Betriu, C., Redondo, M., Palau, M. L., Sánchez, A., Gómez, M., Culebras, E., Boloix, A., Picazo, J. J.
(2000). Comparative In Vitro Activities of Linezolid, Quinupristin-Dalfopristin, Moxifloxacin, and Trovafloxacin against Erythromycin-Susceptible and -Resistant Streptococci. Antimicrob. Agents Chemother.
44: 1838-1841
[Abstract]
[Full Text]
-
Bingen, E., Fitoussi, F., Doit, C., Cohen, R., Tanna, A., George, R., Loukil, C., Brahimi, N., Le Thomas, I., Deforche, D.
(2000). Resistance to Macrolides in Streptococcus pyogenes in France in Pediatric Patients. Antimicrob. Agents Chemother.
44: 1453-1457
[Abstract]
[Full Text]
-
Alos, J. I., Aracil, B., Oteo, J., Torres, C., Gomez-Garces, J. L., the Spanish Group for the Study of Infection in th,
(2000). High prevalence of erythromycin-resistant, clindamycin/miocamycin-susceptible (M phenotype) Streptococcus pyogenes: results of a Spanish multicentre study in 1998. J Antimicrob Chemother
45: 605-609
[Abstract]
[Full Text]
-
Gómez-Lus, R., Granizo, J. J., Aguilar, L., Bouza, E., Gutierrez, A., García-de-Lomas, J., Spanish Surveillance Group for Respiratory Pathoge,
(1999). Is There an Ecological Relationship between Rates of Antibiotic Resistance of Species of the Genus Streptococcus?. J. Clin. Microbiol.
37: 3384-3386
[Abstract]
[Full Text]